Resistance of gluconeogenic and glycogenic pathways in obese-hyperglycemic mice. 1975

W Kreutner, and S C Springer, and J E Sherwood

The genetically obese-hyperglycemic mouse, C57 BL/6J-ob, exhibits hyperglycemia and hyperinsulinemia. We have investigated the in vivo hepatic response to a glucose load in female obese mice and their lean littermates. Within 15 min after the administration of glucose (1.5 g/kg) to fasted lean mice, gluconeogenesis from [14C]alanine markedly decreased, endogenous hepatic levels of alanine and other gluconeogenic precursors increased, and glycogen synthetase was activated by virtue of an increase in the precent of synthetase I. These changes persisted up to 60 min and then returned to fasting values. In contrast, obese mice did not produce any of the above changes when given a similar glucose load. Failure to activate glycogen synthetase occurred despite the presence of synthetase D phosphatase activity. In lean mice [14C]glucose synthesis from [14C]glycerol exceeded that from [14C]alanine and was not suppressed by glucose administration, indicating the site of control of gluconeogenesis to be below the triose phosphate step. Insulin resistance in obese mice may involve the liver, as well as peripheral tissues studied by others.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D005943 Gluconeogenesis Biosynthesis of GLUCOSE from nonhexose or non-carbohydrate precursors, such as LACTATE; PYRUVATE; ALANINE; and GLYCEROL.
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D005990 Glycerol A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, or sweetening agent. 1,2,3-Propanetriol,Glycerin,1,2,3-Trihydroxypropane,Glycerine
D006006 Glycogen Synthase An enzyme that catalyzes the transfer of D-glucose from UDPglucose into 1,4-alpha-D-glucosyl chains. EC 2.4.1.11. Glycogen (Starch) Synthase,Glycogen Synthetase,Glycogen Synthase I,Synthase D,Synthase I,UDP-Glucose Glycogen Glucosyl Transferase,Synthase, Glycogen,Synthetase, Glycogen,UDP Glucose Glycogen Glucosyl Transferase

Related Publications

W Kreutner, and S C Springer, and J E Sherwood
May 1971, Endocrinology,
W Kreutner, and S C Springer, and J E Sherwood
July 1969, Nagoya journal of medical science,
W Kreutner, and S C Springer, and J E Sherwood
January 1967, Biochimica et biophysica acta,
W Kreutner, and S C Springer, and J E Sherwood
May 1972, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
W Kreutner, and S C Springer, and J E Sherwood
August 1984, The Journal of trauma,
W Kreutner, and S C Springer, and J E Sherwood
October 1965, Annals of the New York Academy of Sciences,
W Kreutner, and S C Springer, and J E Sherwood
October 1956, Nutrition reviews,
W Kreutner, and S C Springer, and J E Sherwood
March 1970, The American journal of physiology,
W Kreutner, and S C Springer, and J E Sherwood
February 1974, Metabolism: clinical and experimental,
Copied contents to your clipboard!